Kindred Healthcare, Inc. (KND) Downgraded by Zacks Investment Research
Kindred Healthcare, Inc. (NYSE:KND) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday, May 5th.
According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “
A number of other brokerages have also recently commented on KND. Royal Bank of Canada cut Kindred Healthcare from an “outperform” rating to a “sector perform” rating in a research note on Tuesday, January 31st. Mizuho boosted their target price on Kindred Healthcare from $5.00 to $8.50 and gave the company a “neutral” rating in a research note on Tuesday, February 28th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $10.44.
Kindred Healthcare (NYSE:KND) traded up 1.50% during trading on Friday, hitting $10.15. 57,423 shares of the stock were exchanged. Kindred Healthcare has a 52 week low of $5.65 and a 52 week high of $12.84. The stock’s market capitalization is $869.17 million. The firm has a 50-day moving average of $9.16 and a 200-day moving average of $8.03.
Kindred Healthcare (NYSE:KND) last issued its quarterly earnings results on Wednesday, May 3rd. The health services provider reported $0.04 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.04. The firm had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.78 billion. Kindred Healthcare had a positive return on equity of 5.78% and a negative net margin of 8.31%. Equities research analysts anticipate that Kindred Healthcare will post $0.53 earnings per share for the current fiscal year.
WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/05/19/kindred-healthcare-inc-knd-rating-lowered-to-hold-at-zacks-investment-research-updated.html.
Several large investors have recently bought and sold shares of the stock. Highbridge Capital Management LLC acquired a new stake in shares of Kindred Healthcare during the fourth quarter worth about $300,000. BlackRock Fund Advisors increased its position in shares of Kindred Healthcare by 8.2% in the third quarter. BlackRock Fund Advisors now owns 6,465,561 shares of the health services provider’s stock worth $66,078,000 after buying an additional 489,417 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Kindred Healthcare by 33.7% in the fourth quarter. Renaissance Technologies LLC now owns 259,280 shares of the health services provider’s stock worth $2,035,000 after buying an additional 65,400 shares in the last quarter. UBS Asset Management Americas Inc. increased its position in shares of Kindred Healthcare by 10.7% in the third quarter. UBS Asset Management Americas Inc. now owns 113,881 shares of the health services provider’s stock worth $1,164,000 after buying an additional 11,000 shares in the last quarter. Finally, Comerica Bank increased its position in shares of Kindred Healthcare by 5.5% in the fourth quarter. Comerica Bank now owns 90,575 shares of the health services provider’s stock worth $693,000 after buying an additional 4,686 shares in the last quarter. 94.84% of the stock is owned by institutional investors and hedge funds.
About Kindred Healthcare
Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related stocks with our FREE daily email newsletter.